The Agency for Healthcare Research and Quality (AHRQ) requests that the Office of Management and Budget (OMB) renew under the Paperwork Reduction Act of 1995 AHRQâs Generic Clearance to collect information from users of work products and services initiated by AHRQâs John M. Eisenberg Center for Clinical Decisions and Communications Science (Eisenberg Center). The Eisenberg Center is an innovative effort aimed at improving communication of findings to a variety of audiences (âcustomersâ), including consumers, clinicians, and health care policymakers. The Eisenberg Center compiles research results into a variety of useful formats for customer stakeholders.
This research has the following goals:
1) Conduct research into effective communication of research findings in order to improve the usability and rapid incorporation of findings into medical practice and decision making.
2) Conduct research into effective strategies for disseminating evidence-based products, tools, and resources to consumers, clinicians, and other health care professionals, and policymakers.
3) Evaluate outcomes reported by clinicians and other healthcare professionals resulting from participation in continuing medical education (CME) initiatives and activities.
4) Conduct research into factors associated with successful collaboration between AHRQ and partnering institutions and organizations in synthesizing, translating, and disseminating evidence-based research.
Clearance is being requested to cover a three-year period in which differing numbers of products and research activities may be conducted during each year. The collections proposed include activities to assist in the development of materials to be disseminated through the Eisenberg Center and to provide feedback to AHRQ on the extent to which these products meet customer needs. These materials include summary documents that summarize and translate the findings of research reports for various decision-making audiences, such as consumers, clinicians, or policymakers. The summaries are designed to help these decision makers use research evidence to maximize the benefits of health care, minimize harm, and optimize the use of health care resources. In addition, each year, a unique research project will be undertaken to study successful approaches to disseminating AHRQ products in various health care settings and clinical environments. Also, each year the Eisenberg Center will develop one interactive decision aid for clinical problems identified from selected research reports. The intent is for the decision aid to increase the customerâs knowledge of the health condition, options, and risk/benefits; lead to greater assurance in making a decision; increase the congruence between values and choices; and enhance involvement in the decision making process. Information collections conducted under this generic clearance are not required by regulation and will not be used to regulate or sanction customers. Data collections will be entirely voluntary, and information provided by respondents will be combined and summarized so that no individually identifiable information will be released.
The data collections listed below will be implemented to achieve project goals. Note: Assessments such as interviews and surveys are here denoted formative if conducted prior to product development or determination of dissemination channels; usability testing or pretesting if conducted while reviewing a draft product, proposed dissemination approach, or other proposed content/strategy; and evaluation if conducted for summative evaluation or to assess satisfaction after the product has been in use or the dissemination campaign, learning activity, or other initiative undertaken.
US Code:
42 USC 299
Name of Law: Healthcare Research and Quality Act of 1999
Although AHRQ has requested Clearances from the Office of Management and Budget in the past, the present burden hour request is based on a new contract that includes both (a) product development, dissemination, research, and evaluation tasks identical to those submitted previously yet with greater numbers of products developed, and (b) new projects that have not been reviewed and approved by the Office of Management and Budget. In addition, the proposed work significantly expands the number of products for which CME credit is offered to clinicians, both in this country and abroad, with up to 500 CME participants completing an outcomes assessment survey per CME activity (54 activities across the 3 years). However, the burden associated with each respondent is modest: about 5 minutes to complete the brief survey.
Additionally, the current proposal assumes up to two rounds of data collection associated with the usability testing of 47 products per year. Although this significantly increases the total burden hour estimate, in reality there will be very few circumstances in which a second round of usability testing interviews will be required.
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
60 Day FRN.pdf
OMB L_Outcomes Survey_CME Activities_REV 2016 02 24_2016 08 22.docx